StonvexLoading…
StonvexStonvexStonvexCore line items from SANM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Annual 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $7.20B | $3.19B | $8.13B | $6.03B |
Operating Income | $230.61M | $73.60M | $354.57M | $276.10M |
Net Income | $142.93M | $49.29M | $245.89M | $197.83M |
EPS (Diluted) | $2.58 | $0.89 | $4.46 | $3.58 |
Total Assets | $9.67B | $9.80B | $5.86B | $5.22B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.58B | $1.42B | $926.27M | $797.88M |
Free Cash Flow OCF − CapEx | $433.93M | $91.89M | $473.30M | $336.69M |
Shares Outstanding | 55.31M | 55.52M | 53.40M | 55.28M |